{
  "ticker": "JNJ",
  "target_date": "2025-02-13",
  "actual_date": "2025-02-13",
  "collected_at": "2025-12-08T11:24:06.368864",
  "price": {
    "open": 150.65,
    "high": 153.43,
    "low": 150.19,
    "close": 152.57943725585938,
    "volume": 10704700,
    "change_1d_pct": 1.28,
    "change_7d_pct": 2.45,
    "change_30d_pct": 9.7
  },
  "technicals": {
    "rsi_14": 73.35,
    "sma_20": 147.03,
    "sma_50": 143.89,
    "macd": 2.305,
    "macd_signal": 1.8,
    "macd_histogram": 0.505,
    "bb_upper": 153.82,
    "bb_lower": 140.25,
    "price_vs_sma20_pct": 3.77,
    "price_vs_sma50_pct": 6.04,
    "volume_ratio": 1.13
  },
  "fundamentals": {
    "market_cap": 488833941504,
    "pe_ratio": 19.584461,
    "forward_pe": 19.141037,
    "price_to_book": 6.158224,
    "price_to_sales": 5.304821,
    "profit_margin": 27.26,
    "operating_margin": 30.2,
    "roe": 33.62,
    "roa": 8.26,
    "revenue_growth": 6.8,
    "earnings_growth": 91.0,
    "debt_to_equity": 57.766,
    "current_ratio": 1.074,
    "quick_ratio": 0.711,
    "dividend_yield": 258.0,
    "fifty_two_week_high": 207.81,
    "fifty_two_week_low": 140.68,
    "fifty_day_avg": 193.4922,
    "two_hundred_day_avg": 170.2741,
    "analyst_target": 203.41833,
    "analyst_recommendation": "buy",
    "num_analysts": 24,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -2.37,
    "pct_from_52w_low": 44.22
  },
  "macro": {
    "spy": {
      "price": 604.43,
      "change_1d_pct": 1.06,
      "change_7d_pct": 0.91
    },
    "vix": {
      "level": 15.1,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.53
    },
    "dollar_index": {
      "level": 107.31
    },
    "gold": {
      "price": 2925.9
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Tracking Jeremy Grantham's GMO Capital Portfolio - Q4 2024 Update",
      "source": "SeekingAlpha",
      "datetime": 1739486426,
      "summary": "GMO's portfolio update highlights key stock adjustments and forecasts a promising 9.6% return for International Deep Value assets. See more here.",
      "url": "https://finnhub.io/api/news?id=7fee116fab786340e0e08cc4d8e405c129a8999c0cd921f1dac302c5b6a50dcf"
    },
    {
      "headline": "Janus Henderson Global Life Sciences Diversified ADR Managed Account Q4 2024 Commentary",
      "source": "SeekingAlpha",
      "datetime": 1739480280,
      "summary": "The Portfolio returned -10.75% (gross) and the MSCI World Health Care IndexSM returned -11.32%. Read more here.",
      "url": "https://finnhub.io/api/news?id=8d306981723ae6baaa27a41df72a2ad77528d2ff9fae45eee20d34b6483d2dcd"
    },
    {
      "headline": "Kiniksa Pharmaceuticals: Strong Improvement In Arcalyst Revenue, But Risks Remain",
      "source": "SeekingAlpha",
      "datetime": 1739468968,
      "summary": "Kiniksa Pharmaceuticals stock is attractive because it trades near 52-week lows, and its marketed drug gains traction. Click to find out why KNSA is a Hold.",
      "url": "https://finnhub.io/api/news?id=5d90ca30706ab51288585963e09287df18a5bd0de91ce97d5e6f55d739ca71ee"
    },
    {
      "headline": "Cisco, NVIDIA Corp. share gains lead Dow's nearly 250-point jump",
      "source": "MarketWatch",
      "datetime": 1739455440,
      "summary": "Cisco, NVIDIA Corp. share gains lead Dow's nearly 250-point jump",
      "url": "https://finnhub.io/api/news?id=f21a9de0aaaab51fa9b6824d90ad54d01e5d4da28fd16a9e92447a14204a5fc3"
    },
    {
      "headline": "Tracking Tweedy Browne Portfolio - Q4 2024 Update",
      "source": "SeekingAlpha",
      "datetime": 1739398529,
      "summary": "Tweedy Browne\u00e2\u0080\u0099s 13F portfolio value decreased from $2.10B to $1.48B. Click here to read more about the trades and holdings of the portfolio.",
      "url": "https://finnhub.io/api/news?id=36841fc1a25c10cbffaaa7adcc03b8e81975493129d249f1926d024e62faea3a"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "10-K",
      "date": "2025-02-13",
      "description": "jnj-20241229.htm",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/jnj-20241229.htm"
    },
    {
      "form": "13F-HR",
      "date": "2025-02-13",
      "description": "xslForm13F_X02/primary_doc.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000090445425000124/xslForm13F_X02/primary_doc.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739403530.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000035/xslF345X05/wk-form4_1739403530.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739403421.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000033/xslF345X05/wk-form4_1739403421.xml"
    },
    {
      "form": "4",
      "date": "2025-02-12",
      "description": "xslF345X05/wk-form4_1739403336.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040625000031/xslF345X05/wk-form4_1739403336.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}